Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effect of Oral Laxative Use Before Colorectal Surgery on Intraoperative Surgical Difficulty (OLAX-CRC)

10 september 2026 bijgewerkt door: IBRAHIM DOGAN, Van Training and Research Hospital
This prospective randomized pilot study will evaluate whether the use of an oral laxative before elective laparoscopic colorectal surgery affects small-bowel diameter and intraoperative surgical difficulty. Adult patients scheduled for elective laparoscopic colorectal resection will be randomly assigned to receive either oral laxative plus rectal enema preparation or rectal enema preparation alone. During surgery, the diameters of the jejunum and ileum will be measured using a standardized method. The study will also compare operative difficulty, bowel manipulation time, operation duration, need for additional ports, conversion to open surgery, intraoperative complications, blood loss, and early postoperative outcomes between the two groups. The findings may help clarify whether oral laxative use influences intraoperative conditions during laparoscopic colorectal surgery.

Studie Overzicht

Gedetailleerde beschrijving

Mechanical bowel preparation is commonly used before elective colorectal surgery. Although its effects on postoperative outcomes have been widely investigated, limited evidence is available regarding the effect of oral laxatives on intraoperative small-bowel distension and technical difficulty during laparoscopic colorectal surgery. Increased intraluminal fluid following oral laxative administration may lead to small-bowel distension, potentially impairing surgical exposure and increasing the need for bowel manipulation.

In this study, small-bowel diameter will be assessed intraoperatively using a standardized measurement method after laparoscopic access and establishment of pneumoperitoneum. Jejunal diameter will be measured approximately 50 cm distal to the ligament of Treitz, and ileal diameter approximately 20 cm proximal to the ileocecal valve. Measurements will be performed in the transverse plane without applying mesenteric tension and, when feasible, the mean of two measurements will be recorded. At the end of the operation, the operating surgeon will assess overall operative difficulty using a Likert-type scale ranging from very easy to very difficult. This pilot study is intended to provide preliminary evidence for the design of future adequately powered studies and to support the evaluation of current bowel-preparation practices.

Studietype

Ingrijpend

Inschrijving (Geschat)

60

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

    • Van
      • Van, Van, Turkije (Türkiye), 65300
        • Werving
        • University of Health Sciences Türkiye, Van Training and Research Hospital
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Age 18 years or older
  • Scheduled for elective laparoscopic colorectal resection
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Able and willing to provide written informed consent

Exclusion Criteria:

  • Requirement for emergency surgery
  • Mechanical intestinal obstruction, gastrointestinal perforation, or generalized peritonitis
  • Anticipated extensive intra-abdominal adhesions
  • Active inflammatory bowel disease
  • Pregnancy
  • Serious systemic disease constituting a contraindication to oral laxative use
  • Inability to perform standardized intraoperative small-bowel diameter measurements

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ander
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Oral Laxative Plus Rectal Enema
Participants assigned to this arm will receive preoperative bowel preparation consisting of an oral laxative combined with a rectal enema before elective laparoscopic colorectal surgery.
Participants assigned to the experimental arm will receive an oral laxative as part of preoperative mechanical bowel preparation, in addition to a rectal enema, before elective laparoscopic colorectal surgery. The oral laxative will be administered according to the institution's standard preoperative bowel preparation protocol.
Participants in both study arms will receive a rectal enema as part of preoperative bowel preparation before elective laparoscopic colorectal surgery. Participants in the comparator arm will receive the rectal enema without an oral laxative.
Actieve vergelijker: Rectal Enema Alone
Participants assigned to this arm will receive preoperative bowel preparation consisting of a rectal enema alone, without an oral laxative, before elective laparoscopic colorectal surgery.
Participants in both study arms will receive a rectal enema as part of preoperative bowel preparation before elective laparoscopic colorectal surgery. Participants in the comparator arm will receive the rectal enema without an oral laxative.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Intraoperative Jejunal Diameter
Tijdsspanne: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
Jejunal diameter will be measured in centimeters approximately 50 cm distal to the ligament of Treitz, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension. When feasible, two measurements will be obtained and their mean will be recorded.
Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
Intraoperative Ileal Diameter
Tijdsspanne: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum
Ileal diameter will be measured in centimeters approximately 20 cm proximal to the ileocecal valve, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension. When feasible, two measurements will be obtained and their mean will be recorded.
Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Operative Difficulty Score
Tijdsspanne: At the end of surgery, on the day of the procedure
Overall operative difficulty will be assessed by the operating surgeon at the end of the procedure using a 5-point Likert scale: 1 = very easy, 2 = easy, 3 = moderate, 4 = difficult, and 5 = very difficult. Higher scores indicate greater operative difficulty.
At the end of surgery, on the day of the procedure
Estimated Intraoperative Blood Loss
Tijdsspanne: Intraoperatively, on the day of surgery
The estimated volume of blood lost during surgery, as recorded in the operative and anesthesia records.
Intraoperatively, on the day of surgery
Incidence of Intraoperative Serosal Injury
Tijdsspanne: Intraoperatively, on the day of surgery
The number of participants who experience an unintended serosal injury during surgery, as documented in the operative record.
Intraoperatively, on the day of surgery
Incidence of Intraoperative Organ Injury
Tijdsspanne: Intraoperatively, on the day of surgery
The number of participants who experience an unintended injury to an intra-abdominal organ during surgery, as documented in the operative record.
Intraoperatively, on the day of surgery
Incidence of Intraoperative Bleeding Requiring Intervention
Tijdsspanne: Intraoperatively, on the day of surgery
The number of participants who experience intraoperative bleeding requiring an additional hemostatic intervention beyond routine surgical hemostasis.
Intraoperatively, on the day of surgery
Requirement for an Additional Laparoscopic Port
Tijdsspanne: Intraoperatively, on the day of surgery
The number of participants in whom placement of at least one additional laparoscopic port beyond the planned port configuration is required to complete the procedure.
Intraoperatively, on the day of surgery
Conversion From Laparoscopic to Open Surgery
Tijdsspanne: Intraoperatively, on the day of surgery
The number of participants whose planned laparoscopic procedure is converted to an open surgical approach.
Intraoperatively, on the day of surgery
Incidence of Any Postoperative Complication Within 30 Days
Tijdsspanne: From the day of surgery through postoperative day 30
The number of participants who experience at least one surgery-related postoperative complication within 30 days after surgery. Each participant will be counted once, regardless of the number of complications experienced.
From the day of surgery through postoperative day 30
Incidence of Anastomotic Leakage Within 30 Days
Tijdsspanne: From the day of surgery through postoperative day 30
The number of participants who develop an anastomotic leak within 30 days after surgery, as documented by clinical, radiological, endoscopic, operative, or drainage findings.
From the day of surgery through postoperative day 30
Incidence of Surgical Site Infection Within 30 Days
Tijdsspanne: From the day of surgery through postoperative day 30
The number of participants who develop a surgical site infection within 30 days after surgery, including superficial incisional, deep incisional, or organ/space infection.
From the day of surgery through postoperative day 30
Incidence of Postoperative Ileus Within 30 Days
Tijdsspanne: From the day of surgery through postoperative day 30
The number of participants who develop postoperative ileus within 30 days after surgery, as documented in the medical record based on delayed recovery or interruption of gastrointestinal function.
From the day of surgery through postoperative day 30
Time Required for Bowel Manipulation and Displacement
Tijdsspanne: Intraoperatively, on the day of surgery
The time required to manipulate the bowel and displace it from the operative field during surgery.
Intraoperatively, on the day of surgery
Time Required for Intraoperative Bowel Diameter Measurements
Tijdsspanne: Intraoperatively, on the day of surgery
The time required to perform intraoperative measurements of the jejunal and ileal diameters.
Intraoperatively, on the day of surgery
Time Required to Complete the Anastomosis
Tijdsspanne: Intraoperatively, on the day of surgery
The time from initiation of anastomosis construction to completion of the anastomosis during surgery.
Intraoperatively, on the day of surgery
Total Operation Time
Tijdsspanne: Intraoperatively, on the day of surgery
The total duration of the surgical procedure, defined as the time from skin incision to completion of skin closure.
Intraoperatively, on the day of surgery

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

22 mei 2026

Primaire voltooiing (Geschat)

22 mei 2027

Studie voltooiing (Geschat)

22 juni 2027

Studieregistratiedata

Eerst ingediend

5 september 2026

Eerst ingediend dat voldeed aan de QC-criteria

10 september 2026

Eerst geplaatst (Werkelijk)

15 september 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

15 september 2026

Laatste update ingediend die voldeed aan QC-criteria

10 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren